Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	cell recognition	ADAM18 CNTNAP3 SIRPB1 SIRPA PCDH12 ASTL DCST1 YWHAZ CNTN2 VDAC2	1.19e-05	198	184	10	GO:0008037
GeneOntologyBiologicalProcess	interferon-beta production	IRF5 SIRPB1 SIRPA TICAM2 IFNAR1 ATG9A	4.82e-05	73	184	6	GO:0032608
GeneOntologyBiologicalProcess	regulation of interferon-beta production	IRF5 SIRPB1 SIRPA TICAM2 IFNAR1 ATG9A	4.82e-05	73	184	6	GO:0032648
GeneOntologyBiologicalProcess	detection of mechanical stimulus	PKD2L1 ADGRV1 PKD1L2 PIEZO2 STRC STRCP1	5.61e-05	75	184	6	GO:0050982
GeneOntologyBiologicalProcess	negative regulation of chemokine (C-C motif) ligand 5 production	SIRPB1 SIRPA TICAM2	5.64e-05	9	184	3	GO:0071650
HumanPheno	Renal hypoplasia/aplasia	FAT4 FRAS1 EVC2 DLL4 DYNC2H1 APC2 ADA2 FREM1 FANCA WDR19 PIEZO2 VANGL1 CPLANE1 NODAL FBXW11	1.39e-05	359	61	15	HP:0008678
Domain	-	RBBP4 WDR31 IFT172 PEX7 EIPR1 SEC31B LYST WDR19 WDR93 MET NWD2 WDR97 TULP4 SEMA5B PLXNB1 TBL1X FBXW11	2.32e-08	333	179	17	2.130.10.10
Domain	WD40/YVTN_repeat-like_dom	RBBP4 WDR31 IFT172 PEX7 EIPR1 SEC31B LYST WDR19 WDR93 MET NWD2 WDR97 TULP4 SEMA5B PLXNB1 TBL1X FBXW11	2.53e-08	335	179	17	IPR015943
Domain	WD_REPEATS_1	RBBP4 WDR31 IFT172 PEX7 EIPR1 SEC31B LYST WDR19 WDR93 NWD2 WDR97 TULP4 TBL1X FBXW11	4.99e-07	278	179	14	PS00678
Domain	WD_REPEATS_2	RBBP4 WDR31 IFT172 PEX7 EIPR1 SEC31B LYST WDR19 WDR93 NWD2 WDR97 TULP4 TBL1X FBXW11	5.21e-07	279	179	14	PS50082
Domain	WD_REPEATS_REGION	RBBP4 WDR31 IFT172 PEX7 EIPR1 SEC31B LYST WDR19 WDR93 NWD2 WDR97 TULP4 TBL1X FBXW11	5.21e-07	279	179	14	PS50294
Domain	WD40_repeat_dom	RBBP4 WDR31 IFT172 PEX7 EIPR1 SEC31B LYST WDR19 WDR93 NWD2 WDR97 TULP4 TBL1X FBXW11	1.10e-06	297	179	14	IPR017986
Domain	WD40	RBBP4 WDR31 IFT172 PEX7 EIPR1 SEC31B LYST WDR19 NWD2 WDR97 TULP4 TBL1X FBXW11	1.96e-06	268	179	13	SM00320
Domain	WD40_repeat	RBBP4 WDR31 IFT172 PEX7 EIPR1 SEC31B LYST WDR19 NWD2 WDR97 TULP4 TBL1X FBXW11	2.31e-06	272	179	13	IPR001680
Domain	WD40_repeat_CS	RBBP4 WDR31 PEX7 EIPR1 SEC31B LYST NWD2 WDR97 TBL1X FBXW11	4.18e-06	164	179	10	IPR019775
Domain	WD40	RBBP4 WDR31 IFT172 PEX7 EIPR1 SEC31B LYST WDR19 WDR97 TULP4 TBL1X FBXW11	7.84e-06	259	179	12	PF00400
Domain	Spectrin	SYNE1 SPTBN1 ACTN1 SPTBN5	6.26e-05	23	179	4	PF00435
Domain	ACTININ_2	SYNE1 SPTBN1 ACTN1 SPTBN5	6.26e-05	23	179	4	PS00020
Domain	ACTININ_1	SYNE1 SPTBN1 ACTN1 SPTBN5	6.26e-05	23	179	4	PS00019
Domain	Actinin_actin-bd_CS	SYNE1 SPTBN1 ACTN1 SPTBN5	6.26e-05	23	179	4	IPR001589
Domain	Calx_beta	FRAS1 ADGRV1 FREM1	6.97e-05	9	179	3	IPR003644
Domain	Calx-beta	FRAS1 ADGRV1 FREM1	6.97e-05	9	179	3	PF03160
Domain	DUF2181	FAM151B FAM151A	9.13e-05	2	179	2	IPR019356
Domain	DUF2181	FAM151B FAM151A	9.13e-05	2	179	2	PF10223
Domain	Dopey_N	DOP1A DOP1B	9.13e-05	2	179	2	PF04118
Domain	Dopey_N	DOP1A DOP1B	9.13e-05	2	179	2	IPR007249
Domain	NADH_UbQ_FeS_4_mit	NDUFS4 WDR93	9.13e-05	2	179	2	IPR006885
Domain	Spectrin_repeat	SYNE1 SPTBN1 ACTN1 SPTBN5	1.61e-04	29	179	4	IPR002017
Domain	SPEC	SYNE1 SPTBN1 ACTN1 SPTBN5	2.38e-04	32	179	4	SM00150
Domain	Spectrin/alpha-actinin	SYNE1 SPTBN1 ACTN1 SPTBN5	2.38e-04	32	179	4	IPR018159
Domain	ConA-like_dom	FAT4 LGALS16 CNTNAP3 LAMA5 ADGRV1 CMYA5 MAMDC4 ASH2L LGALS4	2.70e-04	219	179	9	IPR013320
Domain	GPS	ADGRV1 PKD1L2 ADGRE3 ADGRL3	3.02e-04	34	179	4	SM00303
Domain	-	FAT4 LGALS16 CNTNAP3 LAMA5 ADGRV1 LGALS4	3.06e-04	95	179	6	2.60.120.200
Domain	GPS	ADGRV1 PKD1L2 ADGRE3 ADGRL3	3.39e-04	35	179	4	PF01825
Domain	GPS	ADGRV1 PKD1L2 ADGRE3 ADGRL3	3.78e-04	36	179	4	PS50221
Domain	CH	SYNE1 SPTBN1 ACTN1 SPTBN5 MICAL2	3.97e-04	65	179	5	SM00033
Domain	GPS	ADGRV1 PKD1L2 ADGRE3 ADGRL3	4.21e-04	37	179	4	IPR000203
Domain	FN3	NPHS1 SDK2 CMYA5 LRIT3 IFNAR1 CSF2RB HCFC1 CNTN2	4.21e-04	185	179	8	SM00060
Domain	Ig-like_fold	NPHS1 SDK2 CAMTA2 SIRPB1 SIRPA CMYA5 LRIT3 IFNAR1 MET CSF2RB MICB LINGO4 KIRREL1 HCFC1 CNTN2 PLXNB1 IGSF3	4.61e-04	706	179	17	IPR013783
Domain	CH	SYNE1 SPTBN1 ACTN1 SPTBN5 MICAL2	5.59e-04	70	179	5	PF00307
Domain	-	SYNE1 SPTBN1 ACTN1 SPTBN5 MICAL2	5.97e-04	71	179	5	1.10.418.10
Domain	-	NPHS1 SDK2 SIRPB1 SIRPA CMYA5 LRIT3 IFNAR1 MET CSF2RB MICB LINGO4 KIRREL1 HCFC1 CNTN2 PLXNB1 IGSF3	6.63e-04	663	179	16	2.60.40.10
Domain	CH	SYNE1 SPTBN1 ACTN1 SPTBN5 MICAL2	6.78e-04	73	179	5	PS50021
Domain	FN3	NPHS1 SDK2 CMYA5 LRIT3 IFNAR1 CSF2RB HCFC1 CNTN2	6.82e-04	199	179	8	PS50853
Domain	EGF-like_dom	FAT4 FRAS1 DLL4 ADAM18 CNTNAP3 LAMA5 PTGS1 ADGRE3 MUC4	6.85e-04	249	179	9	IPR000742
Domain	CH-domain	SYNE1 SPTBN1 ACTN1 SPTBN5 MICAL2	7.67e-04	75	179	5	IPR001715
Domain	Gal_Lectin	PKD1L2 ADGRL3	8.96e-04	5	179	2	PF02140
Domain	PKD_2	PKD2L1 PKD1L2	8.96e-04	5	179	2	IPR003915
Domain	Lectin_gal-bd_dom	PKD1L2 ADGRL3	8.96e-04	5	179	2	IPR000922
Domain	SUEL_LECTIN	PKD1L2 ADGRL3	8.96e-04	5	179	2	PS50228
Domain	FN3_dom	NPHS1 SDK2 CMYA5 LRIT3 IFNAR1 CSF2RB HCFC1 CNTN2	9.37e-04	209	179	8	IPR003961
Domain	PSI	MET SEMA5B SLC2A13 PLXNB1	9.72e-04	46	179	4	SM00423
Domain	TFR_dimer	NAALADL1 FOLH1B	1.34e-03	6	179	2	PF04253
Domain	-	NAALADL1 FOLH1B	1.34e-03	6	179	2	1.20.930.40
Domain	G-protein_beta_WD-40_rep	RBBP4 WDR31 PEX7 TBL1X FBXW11	1.35e-03	85	179	5	IPR020472
Domain	SMAD_FHA_domain	KIF13B IRF5 STARD9 SLMAP	1.54e-03	52	179	4	IPR008984
Domain	ARM-type_fold	DNAJC13 IFT172 APC2 LYST PPP4R4 KPNA7 THADA NOC4L TARBP1 KPNA1	1.64e-03	339	179	10	IPR016024
Domain	14_3_3	YWHAZ YWHAQ	1.86e-03	7	179	2	SM00101
Domain	1433_1	YWHAZ YWHAQ	1.86e-03	7	179	2	PS00796
Domain	1433_2	YWHAZ YWHAQ	1.86e-03	7	179	2	PS00797
Domain	Arm_3	KPNA7 KPNA1	1.86e-03	7	179	2	PF16186
Domain	14-3-3_domain	YWHAZ YWHAQ	1.86e-03	7	179	2	IPR023410
Domain	14-3-3_CS	YWHAZ YWHAQ	1.86e-03	7	179	2	IPR023409
Domain	14-3-3	YWHAZ YWHAQ	1.86e-03	7	179	2	PF00244
Domain	TLV_coat	ERVFC1 ERVFRD-1	1.86e-03	7	179	2	PF00429
Domain	Importing_su_alpha	KPNA7 KPNA1	1.86e-03	7	179	2	IPR024931
Domain	TFR-like_dimer_dom	NAALADL1 FOLH1B	1.86e-03	7	179	2	IPR007365
Domain	IBB	KPNA7 KPNA1	1.86e-03	7	179	2	PF01749
Domain	Arm_3	KPNA7 KPNA1	1.86e-03	7	179	2	IPR032413
Domain	EGF	FAT4 FRAS1 DLL4 CNTNAP3 LAMA5 PTGS1 ADGRE3 MUC4	1.97e-03	235	179	8	SM00181
Domain	FHA	KIF13B STARD9 SLMAP	2.38e-03	28	179	3	SM00240
Domain	14-3-3	YWHAZ YWHAQ	2.46e-03	8	179	2	IPR000308
Domain	IBB	KPNA7 KPNA1	2.46e-03	8	179	2	PS51214
Domain	Calx_beta	FRAS1 ADGRV1	2.46e-03	8	179	2	SM00237
Domain	TLV/ENV_coat_polyprotein	ERVFC1 ERVFRD-1	2.46e-03	8	179	2	IPR018154
Domain	PH_dom-spectrin-type	SPTBN1 SPTBN5	3.15e-03	9	179	2	IPR001605
Domain	Importin-a_IBB	KPNA7 KPNA1	3.15e-03	9	179	2	IPR002652
Domain	Semap_dom	MET SEMA5B PLXNB1	3.19e-03	31	179	3	IPR001627
Domain	SEMA	MET SEMA5B PLXNB1	3.19e-03	31	179	3	PS51004
Domain	TIG	CAMTA2 MET PLXNB1	3.19e-03	31	179	3	PF01833
Domain	Arm	APC2 KPNA7 KPNA1	3.19e-03	31	179	3	PF00514
Domain	Sema	MET SEMA5B PLXNB1	3.19e-03	31	179	3	SM00630
Domain	Sema	MET SEMA5B PLXNB1	3.19e-03	31	179	3	PF01403
Domain	FHA	KIF13B STARD9 SLMAP	3.19e-03	31	179	3	PF00498
Pathway	REACTOME_SEMA4D_MEDIATED_INHIBITION_OF_CELL_ATTACHMENT_AND_MIGRATION	MET RND1 PLXNB1	3.69e-05	8	125	3	M27325
Pathway	REACTOME_SEMA4D_MEDIATED_INHIBITION_OF_CELL_ATTACHMENT_AND_MIGRATION	MET RND1 PLXNB1	3.69e-05	8	125	3	MM15045
Pathway	REACTOME_NEPHRIN_FAMILY_INTERACTIONS	NPHS1 SPTBN1 ACTN1 KIRREL1	4.58e-05	23	125	4	M913
Pubmed	Direct interaction of Rnd1 with Plexin-B1 regulates PDZ-RhoGEF-mediated Rho activation by Plexin-B1 and induces cell contraction in COS-7 cells.	RND3 MET RND1 PLXNB1	1.73e-07	10	189	4	12730235
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	USP36 SDK2 UBAP2 LAMA5 ADGRV1 FRMD4B WDR19 SEMA5B HECW2 SLMAP TNKS1BP1 YWHAQ CRAMP1 PLXNB1 IGSF3	2.38e-07	529	189	15	14621295
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	CACNA2D1 FAT4 FRAS1 RBBP4 PROCR CNTNAP3 LAMA5 TMEM214 PTGS1 FANCA MET THADA P2RX5 MICAL2 PRMT5 KIRREL1 TNKS1BP1 TAP2 GNS PLXNB1 IGSF3 DNMT1	7.18e-07	1201	189	22	35696571
Pubmed	Analysis of the interaction of Plexin-B1 and Plexin-B2 with Rnd family proteins.	RND3 RND1 PLXNB1	1.57e-06	5	189	3	29040270
Pubmed	Signal regulatory protein alpha negatively regulates both TLR3 and cytoplasmic pathways in type I interferon induction.	SIRPB1 SIRPA IFNB1	1.57e-06	5	189	3	18471880
Pubmed	The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment.	UBAP2 CPXM2 DLL4 ADAM18 ATP13A5 LINC02910 FAM131A LRRTM3 PCDH12 MAMDC4 FAM151B PRSS53 SEMA5B FAM151A ADGRE3 SLMAP LINGO4 ERVFRD-1 SFT2D2	2.05e-06	985	189	19	12975309
Pubmed	Interferon-Regulatory Factor 5-Dependent Signaling Restricts Orthobunyavirus Dissemination to the Central Nervous System.	IRF5 IFNAR1 IFNB1	3.12e-06	6	189	3	26468541
Pubmed	The protein-tyrosine phosphatase SHP-1 regulates the phosphorylation of alpha-actinin.	SIRPB1 SIRPA ACTN1	3.12e-06	6	189	3	15070900
Pubmed	Identification of splicing variants of Rapostlin, a novel RND2 effector that interacts with neural Wiskott-Aldrich syndrome protein and induces neurite branching.	RND3 RND1 PLXNB1	3.12e-06	6	189	3	14732713
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	KIF13B UAP1 UBAP2 SPTBN1 CCDC18 LYST YWHAZ PABIR2 PPP4R4 CEP112 STARD9 PRMT5 TNKS1BP1 YWHAQ DOP1A DNMT1 DOP1B	5.34e-06	861	189	17	36931259
Pubmed	The GTPase-deficient Rnd proteins are stabilized by their effectors.	RND3 RND1 PLXNB1	5.44e-06	7	189	3	22807448
Pubmed	Proteomic identification of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells.	RBBP4 ACP2 SPTBN1 LAMA5 TMEM214 YWHAZ PTGS1 MET ATAD3B PRMT5 YWHAQ GNS IGSF3 VDAC2	7.44e-06	613	189	14	22268729
Pubmed	14-3-3 proteins interact with a hybrid prenyl-phosphorylation motif to inhibit G proteins.	YWHAZ RND3 YWHAQ	8.67e-06	8	189	3	23622247
Pubmed	p190 Rho-GTPase activating protein associates with plexins and it is required for semaphorin signalling.	MET RND1 PLXNB1	8.67e-06	8	189	3	16188938
Pubmed	Mice deficient in alpha-actinin-4 have severe glomerular disease.	NPHS1 ACTN1 KIRREL1	8.67e-06	8	189	3	12782671
Pubmed	Phospho-proteomic analyses of B-Raf protein complexes reveal new regulatory principles.	DNAJC13 YWHAZ ATAD3B VANGL1 PLD2 YWHAQ	9.51e-06	89	189	6	27034005
Pubmed	ZFP36L2 is a cell cycle-regulated CCCH protein necessary for DNA lesion-induced S-phase arrest.	SPTBN1 CMYA5 YWHAZ LRRC9 SPTBN5 SBNO1 PRMT5 YWHAQ	9.86e-06	189	189	8	29449217
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	NPHS1 VIL1 CACNA2D1 DNAJC13 DYNC2H1 ACP2 SPTBN1 LAMA5 SIRPA ACTN1 ADGRV1 SHROOM2 YWHAZ HP FAM151A YWHAQ DOP1B SFT2D2	1.22e-05	1016	189	18	19056867
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	CACNA2D1 RBBP4 IFT172 SPTBN1 SNX33 LMTK3 YWHAZ NWD2 PRMT5 YWHAQ DNMT1 FBXW11	1.26e-05	475	189	12	31040226
Pubmed	In Vivo Visualizing the IFN-β Response Required for Tumor Growth Control in a Therapeutic Model of Polyadenylic-Polyuridylic Acid Administration.	IRF5 IFNAR1 IFNB1	1.30e-05	9	189	3	26880763
Pubmed	Impaired OTUD7A-dependent Ankyrin regulation mediates neuronal dysfunction in mouse and human models of the 15q13.3 microdeletion syndrome.	SDK2 ANK2 SPTBN1 TULP4 VANGL1 TNKS1BP1 NOS1 ADGRL3	1.33e-05	197	189	8	36604605
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	FRAS1 IFT172 SYNE1 CAMTA2 CSMD3 STARD9 ULK1 VPS13B ADGRL3 DOP1B PDZD2	1.57e-05	407	189	11	12693553
Pubmed	Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells.	SIRPB1 SIRPA LYST	1.84e-05	10	189	3	17982459
Pubmed	Induction of IFN-beta and the innate antiviral response in myeloid cells occurs through an IPS-1-dependent signal that does not require IRF-3 and IRF-7.	IRF5 IFNAR1 IFNB1	1.84e-05	10	189	3	19798431
Pubmed	Cullin 1 (CUL1) Promotes Primary Ciliogenesis through the Induction of Ubiquitin-Proteasome-Dependent Dvl2 Degradation.	VIL1 FRAS1 SYNE1 ATP9B ADGRV1 FREM1 ATAD3B	2.08e-05	152	189	7	34299191
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	FRAS1 DNAJC13 ANK2 RBBP4 DYNC2H1 SYNE1 SPTBN1 CCDC18 TMEM214 NDUFS4 WDR19 MET PNPT1 ATAD3B THADA VANGL1 SLMAP NOC4L KIRREL1 MRPL40 VPS13B DNMT1	2.13e-05	1487	189	22	33957083
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	KIF13B CACNA2D1 DNAJC13 UBAP2 ANK2 SYNE1 SPTBN1 APC2 SIRPB1 SIRPA LMTK3 YWHAZ YWHAQ NOS1 DNMT1 TBL1X KPNA1	2.25e-05	963	189	17	28671696
Pubmed	Metabolic-stress-induced rearrangement of the 14-3-3ζ interactome promotes autophagy via a ULK1- and AMPK-regulated 14-3-3ζ interaction with phosphorylated Atg9.	YWHAZ ULK1 ATG9A	2.52e-05	11	189	3	25266655
Pubmed	The IFT-A complex regulates Shh signaling through cilia structure and membrane protein trafficking.	DYNC2H1 IFT172 WDR19	2.52e-05	11	189	3	22689656
Pubmed	Up-regulation of human PNPase mRNA by beta-interferon has no effect on protein level in melanoma cell lines.	IFNB1 PNPT1	2.94e-05	2	189	2	16505900
Pubmed	Differential tyrosine phosphorylation of the IFNAR chain of the type I interferon receptor and of an associated surface protein in response to IFN-alpha and IFN-beta.	IFNAR1 IFNB1	2.94e-05	2	189	2	7813427
Pubmed	Type I IFN negatively regulates CD8+ T cell responses through IL-10-producing CD4+ T regulatory 1 cells.	IFNAR1 IFNB1	2.94e-05	2	189	2	15611232
Pubmed	TDRD6 mediates early steps of spliceosome maturation in primary spermatocytes.	PRMT5 TDRD6	2.94e-05	2	189	2	28263986
Pubmed	Phosphorylation of slit diaphragm proteins NEPHRIN and NEPH1 upon binding of HGF promotes podocyte repair.	NPHS1 KIRREL1	2.94e-05	2	189	2	34391780
Pubmed	The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling.	RND1 PLXNB1	2.94e-05	2	189	2	25531777
Pubmed	Cyclosporin a inhibits rotavirus replication and restores interferon-beta signaling pathway in vitro and in vivo.	IRF5 IFNB1	2.94e-05	2	189	2	23990993
Pubmed	βII-spectrin promotes mouse brain connectivity through stabilizing axonal plasma membranes and enabling axonal organelle transport.	ANK2 SPTBN1	2.94e-05	2	189	2	31209033
Pubmed	Effects of type I interferons on Friend retrovirus infection.	IFNAR1 IFNB1	2.94e-05	2	189	2	16537611
Pubmed	Dual-vector gene therapy restores cochlear amplification and auditory sensitivity in a mouse model of DFNB16 hearing loss.	STRC STRCP1	2.94e-05	2	189	2	34910522
Pubmed	14-3-3ζ mediates an alternative, non-thermogenic mechanism in male mice to reduce heat loss and improve cold tolerance.	YWHAZ YWHAQ	2.94e-05	2	189	2	32668300
Pubmed	Autophagy initiation by ULK complex assembly on ER tubulovesicular regions marked by ATG9 vesicles.	ULK1 ATG9A	2.94e-05	2	189	2	27510922
Pubmed	Blockade of interferon Beta, but not interferon alpha, signaling controls persistent viral infection.	IFNAR1 IFNB1	2.94e-05	2	189	2	25974304
Pubmed	Ankyrin-B targets beta2-spectrin to an intracellular compartment in neonatal cardiomyocytes.	ANK2 SPTBN1	2.94e-05	2	189	2	15262991
Pubmed	Morphogenesis in Aspergillus nidulans requires Dopey (DopA), a member of a novel family of leucine zipper-like proteins conserved from yeast to humans.	DOP1A DOP1B	2.94e-05	2	189	2	10931277
Pubmed	Persistent viral infection elevates central nervous system MHC class I through chronic production of interferons.	IFNAR1 IFNB1	2.94e-05	2	189	2	19717517
Pubmed	The alpha/beta interferon response controls tissue tropism and pathogenicity of poliovirus.	IFNAR1 IFNB1	2.94e-05	2	189	2	15767446
Pubmed	Oncolytic virus-derived type I interferon restricts CAR T cell therapy.	IFNAR1 IFNB1	2.94e-05	2	189	2	32581235
Pubmed	Co-expression of plexin-B1 and Met in human breast and ovary tumours enhances the risk of progression.	MET PLXNB1	2.94e-05	2	189	2	19940359
Pubmed	Overlapping and divergent localization of Frem1 and Fras1 and its functional implications during mouse embryonic development.	FRAS1 FREM1	2.94e-05	2	189	2	17240369
Pubmed	Type I interferons produced by dendritic cells promote their phenotypic and functional activation.	IFNAR1 IFNB1	2.94e-05	2	189	2	11964292
Pubmed	Evidence for a founder effect for pseudoxanthoma elasticum in the Afrikaner population of South Africa.	ABCC6 FANCA	2.94e-05	2	189	2	12384774
Pubmed	Mutations in a new gene encoding a protein of the hair bundle cause non-syndromic deafness at the DFNB16 locus.	STRC STRCP1	2.94e-05	2	189	2	11687802
Pubmed	SIRPα interacts with nephrin at the podocyte slit diaphragm.	NPHS1 SIRPA	2.94e-05	2	189	2	22747997
Pubmed	Type I IFNs stimulate nitric oxide production and resistance to Trypanosoma cruzi infection.	IFNAR1 IFNB1	2.94e-05	2	189	2	16920958
Pubmed	OGG1 regulates the level of symmetric dimethylation of histone H4 arginine-3 by interacting with PRMT5.	OGG1 PRMT5	2.94e-05	2	189	2	29409673
Pubmed	Homodimerization and heterodimerization of the glomerular podocyte proteins nephrin and NEPH1.	NPHS1 KIRREL1	2.94e-05	2	189	2	12660326
Pubmed	Plexin B1 suppresses c-Met in melanoma: a role for plexin B1 as a tumor-suppressor protein through regulation of c-Met.	MET PLXNB1	2.94e-05	2	189	2	20164843
Pubmed	Localized delivery of interferon-β by Lactobacillus exacerbates experimental colitis.	IFNAR1 IFNB1	2.94e-05	2	189	2	21365015
Pubmed	Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1.	IFNAR1 IFNB1	2.94e-05	2	189	2	22258259
Pubmed	Dysfunction in the βII spectrin-dependent cytoskeleton underlies human arrhythmia.	ANK2 SPTBN1	2.94e-05	2	189	2	25632041
Pubmed	Starvation and ULK1-dependent cycling of mammalian Atg9 between the TGN and endosomes.	ULK1 ATG9A	2.94e-05	2	189	2	16940348
Pubmed	Type I Interferon Receptor Signaling in Astrocytes Regulates Hippocampal Synaptic Plasticity and Cognitive Function of the Healthy CNS.	IFNAR1 IFNB1	2.94e-05	2	189	2	32433975
Pubmed	Type I interferons increase host susceptibility to Trypanosoma cruzi infection.	IFNAR1 IFNB1	2.94e-05	2	189	2	21402764
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	CACNA2D1 ADCY4 DNAJC13 ANK2 SYNE1 SPTBN1 ACTN1 SHROOM2 OMG YWHAZ NDUFS4 ATAD3B NWD2 MICAL2 HECW2 PRMT5 TNKS1BP1 YWHAQ NOS1 CNTN2 VDAC2	3.74e-05	1431	189	21	37142655
Pubmed	Type I interferon signaling is required for activation of the inflammasome during Francisella infection.	TICAM2 IFNAR1 IFNB1	4.34e-05	13	189	3	17452523
Pubmed	14-3-3 proteins regulate a cell-intrinsic switch from sonic hedgehog-mediated commissural axon attraction to repulsion after midline crossing.	YWHAZ YWHAQ CNTN2	4.34e-05	13	189	3	23177959
Pubmed	Quantitative dissection and stoichiometry determination of the human SET1/MLL histone methyltransferase complexes.	RBBP4 ASH2L ATAD3B TARBP1 HCFC1 KPNA1	4.96e-05	119	189	6	23508102
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	FAT4 DYNC2H1 SEC31B ASH2L ABCC6 PPP4R4 WDR19 ATAD3B TRAPPC12 LPO TARBP1 IGSF3 KPNA1	5.14e-05	638	189	13	31182584
Pubmed	Probing nuclear pore complex architecture with proximity-dependent biotinylation.	SYNE1 TMEM214 CSMD3 GUCY2D PDZD2	6.47e-05	77	189	5	24927568
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	KIF13B ANK2 SIRPA MET PIEZO2 MICAL2 VANGL1 KIRREL1 VPS13B PLXNB1 IGSF3 SFT2D2	7.25e-05	569	189	12	30639242
Pubmed	Kelch Domain of Gigaxonin Interacts with Intermediate Filament Proteins Affected in Giant Axonal Neuropathy.	CCDC73 DYNC2H1 SYNE1 SPTBN5 SEMA5B PRMT5 IGSF3	7.79e-05	187	189	7	26460568
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	ANK2 IFT172 SYNE1 SPTBN1 APC2 ACTN1 CMYA5 SEC31B SHROOM2 FRMD4B YWHAZ WDR19 SBNO1 MICAL2 TARBP1 DNMT1 FBXW11 DOP1B KPNA1	8.09e-05	1285	189	19	35914814
Pubmed	SIRPα maintains macrophage homeostasis by interacting with PTK2B kinase in Mycobacterium tuberculosis infection and through autophagy and necroptosis.	SIRPB1 SIRPA	8.78e-05	3	189	2	36202053
Pubmed	Src homology 2 domain-containing protein tyrosine phosphatase substrate 1 regulates the migration of Langerhans cells from the epidermis to draining lymph nodes.	SIRPB1 SIRPA	8.78e-05	3	189	2	15034021
Pubmed	Genetic and chemical inhibition of IRF5 suppresses pre-existing mouse lupus-like disease.	IRF5 IFNAR1	8.78e-05	3	189	2	34282144
Pubmed	Cochlear outer hair cell horizontal top connectors mediate mature stereocilia bundle mechanics.	STRC STRCP1	8.78e-05	3	189	2	30801007
Pubmed	Phosphorylation and specific ubiquitin acceptor sites are required for ubiquitination and degradation of the IFNAR1 subunit of type I interferon receptor.	IFNAR1 FBXW11	8.78e-05	3	189	2	15337770
Pubmed	Imaging of Glioblastoma Tumor-Associated Myeloid Cells Using Nanobodies Targeting Signal Regulatory Protein Alpha.	SIRPB1 SIRPA	8.78e-05	3	189	2	34917090
Pubmed	Inhibitory regulation of osteoclast bone resorption by signal regulatory protein alpha.	SIRPB1 SIRPA	8.78e-05	3	189	2	19667119
Pubmed	SIRPA-Inhibited, Marrow-Derived Macrophages Engorge, Accumulate, and Differentiate in Antibody-Targeted Regression of Solid Tumors.	SIRPB1 SIRPA	8.78e-05	3	189	2	28669759
Pubmed	Critical role for protein tyrosine phosphatase SHP-1 in controlling infection of central nervous system glia and demyelination by Theiler's murine encephalomyelitis virus.	SIRPB1 SIRPA	8.78e-05	3	189	2	12134038
Pubmed	Central nervous system antigen P84 can serve as a substrate for neurite outgrowth.	SIRPB1 SIRPA	8.78e-05	3	189	2	2303162
Pubmed	SHPS-1 promotes the survival of circulating erythrocytes through inhibition of phagocytosis by splenic macrophages.	SIRPB1 SIRPA	8.78e-05	3	189	2	16141346
Pubmed	A role for SHPS-1/SIRPalpha in Concanavalin A-dependent production of MMP-9.	SIRPB1 SIRPA	8.78e-05	3	189	2	17825046
Pubmed	SIRPα deficiency accelerates the pathologic process in models of Parkinson disease.	SIRPB1 SIRPA	8.78e-05	3	189	2	31322787
Pubmed	Tick-borne flaviviruses antagonize both IRF-1 and type I IFN signaling to inhibit dendritic cell function.	IFNAR1 IFNB1	8.78e-05	3	189	2	24532583
Pubmed	An essential role for IFN-β in the induction of IFN-stimulated gene expression by LPS in macrophages.	IFNAR1 IFNB1	8.78e-05	3	189	2	25024400
Pubmed	Structural basis of a unique interferon-β signaling axis mediated via the receptor IFNAR1.	IFNAR1 IFNB1	8.78e-05	3	189	2	23872679
Pubmed	The Rho kinase pathway regulates the migration of dendritic cells through SIRP-α.	SIRPB1 SIRPA	8.78e-05	3	189	2	22391241
Pubmed	Expression of recipient CD47 on rat insulinoma cell xenografts prevents macrophage-mediated rejection through SIRPα inhibitory signaling in mice.	SIRPB1 SIRPA	8.78e-05	3	189	2	23472187
Pubmed	SIRP/CD47 signaling in neurological disorders.	SIRPB1 SIRPA	8.78e-05	3	189	2	25795378
Pubmed	Molecular dynamics and in vitro analysis of Connexin43: A new 14-3-3 mode-1 interacting protein.	YWHAZ YWHAQ	8.78e-05	3	189	2	17008717
Pubmed	Deficiency in SIRP-α cytoplasmic recruitment confers protection from acute kidney injury.	SIRPB1 SIRPA	8.78e-05	3	189	2	31370677
Pubmed	Cardiac phospholipase D2 localizes to sarcolemmal membranes and is inhibited by alpha-actinin in an ADP-ribosylation factor-reversible manner.	ACTN1 PLD2	8.78e-05	3	189	2	10801846
Pubmed	A functional subset of CD8+ T cells during chronic exhaustion is defined by SIRPα expression.	SIRPB1 SIRPA	8.78e-05	3	189	2	30770827
Pubmed	Signal regulatory protein α protects podocytes through promoting autophagic activity.	SIRPB1 SIRPA	8.78e-05	3	189	2	30888336
Pubmed	Podocyte SIRPα reduction aggravates lupus nephritis via promoting T cell inflammatory responses.	SIRPB1 SIRPA	8.78e-05	3	189	2	38758648
Pubmed	Protective role of beta interferon in host defense against influenza A virus.	IFNAR1 IFNB1	8.78e-05	3	189	2	17151098
Pubmed	Requirement of SIRPα for protective immunity against Leishmania major.	SIRPB1 SIRPA	8.78e-05	3	189	2	20854790
Pubmed	[Endogenous IFN-β maintains M1 polarization status and inhibits proliferation and invasion of hepatocellular carcinoma cells].	IRF5 IFNB1	8.78e-05	3	189	2	27363262
Interaction	PLEKHG5 interactions	YWHAZ RND3 RND1 YWHAQ VDAC2 FBXW11	1.08e-06	38	182	6	int:PLEKHG5
Interaction	CEACAM8 interactions	CACNA2D1 FAT4 FRAS1 SDK2 CNTNAP3 LAMA5 ADGRV1 IGSF3	1.27e-05	119	182	8	int:CEACAM8
Interaction	OTUD7A interactions	ANK2 SPTBN1 TNKS1BP1 YWHAQ NOS1 ADGRL3	1.37e-05	58	182	6	int:OTUD7A
GeneFamily	WD repeat domain containing	RBBP4 WDR31 IFT172 PEX7 EIPR1 SEC31B LYST WDR19 WDR93 WDR97 TULP4 TBL1X FBXW11	4.45e-08	262	128	13	362
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	APC2 KPNA7 THADA KPNA1	2.39e-04	43	128	4	409
GeneFamily	CD molecules\|V-set domain containing\|C1-set domain containing\|Signal regulatory proteins	SIRPB1 SIRPA	4.90e-04	5	128	2	747
GeneFamily	EF-hand domain containing\|Spectrins	SPTBN1 SPTBN5	1.02e-03	7	128	2	1113
GeneFamily	14-3-3 phospho-serine/phospho-threonine binding proteins	YWHAZ YWHAQ	1.02e-03	7	128	2	1053
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF13B CACNA2D1 FRAS1 SDK2 FANCA PRSS53 FAM151A MUC4 DOP1A	5.78e-08	174	188	9	f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 FRAS1 ADGRV1 PKD1L2 CSMD3 FREM1 PIEZO2 ADGRL3 CNTN2	9.34e-08	184	188	9	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 FRAS1 ADGRV1 PKD1L2 CSMD3 FREM1 PIEZO2 ADGRL3 CNTN2	9.34e-08	184	188	9	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 FRAS1 ADGRV1 PKD1L2 CSMD3 FREM1 PIEZO2 ADGRL3 CNTN2	9.34e-08	184	188	9	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK2 SIRPA LMTK3 EMILIN1 PRSS53 FAM151A SLC2A13 MUC4 GNS	1.53e-07	195	188	9	bd8e24dd598990204998d1dd853ba7a53dc0107e
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	CACNA2D1 FAT4 SPTBN1 LRRTM3 EMILIN1 FRMD4B FREM1 RND3 PIEZO2	1.53e-07	195	188	9	0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
ToppCell	droplet-Kidney-nan-18m-Epithelial-Pecam____kidney_capillary_endothelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NPHS1 FAT4 LRRTM3 PCDH12 PIEZO2 CEP112 HECW2 KIRREL1	6.29e-07	169	188	8	87116c33c5ca8cb1862e103e5607b1df4d264569
ToppCell	Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	CACNA2D1 FRAS1 SYNE1 FAM131A YWHAZ NWD2 SBNO1 MICAL2	8.19e-07	175	188	8	ff0789f5913c9f3c49159e40b1ec3d2ff175ec9f
ToppCell	Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	CACNA2D1 FRAS1 SYNE1 FAM131A YWHAZ NWD2 SBNO1 MICAL2	8.19e-07	175	188	8	21f8f11a8b874d4f7c47931010a2535f2a5a3373
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF13B CACNA2D1 FRAS1 SDK2 PRSS53 FAM151A RLIM MUC4	9.31e-07	178	188	8	fcbbcc44271515de1969b4732b6441c012693d5f
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CACNA2D1 FAT4 SPTBN1 EMILIN1 FRMD4B FREM1 RND3 PIEZO2	1.78e-06	194	188	8	b1bb0f846d2865efdd9bc8842b16b9d069785882
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SDK2 ANK2 SYNE1 LRRTM3 EMILIN1 FREM1 PIEZO2 SORCS3	1.78e-06	194	188	8	60622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SDK2 ANK2 LRRTM3 EMILIN1 FREM1 RND3 PIEZO2 SORCS3	1.78e-06	194	188	8	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VIL1 ANK2 SIRPA EMILIN1 PRSS53 FAM151A MUC4 GNS	1.84e-06	195	188	8	58b769da05a8f6b05aeb08d4f8b112941087ad00
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ANK2 DYNC2H1 SYNE1 SPTBN1 EMILIN1 FREM1 RND3 SORCS3	2.23e-06	200	188	8	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	Myeloid-Myeloid-E_(Neutrophils)\|Myeloid / shred on cell class and cell subclass (v4)	SYNE1 ACTN1 LRRC58 LYST RND1 HP FES	3.54e-06	150	188	7	1bffb8d86b737ac43be902d9468041aef3542f1f
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CATSPERZ PARG CENPO PNPT1 RSAD2 P2RX5 GUCY2D	3.86e-06	152	188	7	18194f757d319958f26e5a91f56d89f25711236f
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KIF13B CPXM2 DLL4 EIPR1 CSMD3 DOP1B PDZD2	6.62e-06	165	188	7	dc570154baed59ed109e5369589448e075ba66a9
ToppCell	metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac\|Myeloid_cells / Location, Cell class and cell subclass	LMTK3 FAM151B RND1 HP LPO ZNF324 ATG9A	7.75e-06	169	188	7	dba8f5599aa21feef5b7fdfed2e3ab54748d80f7
ToppCell	facs-Heart-LV-18m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA2D1 IFT172 EMILIN1 RND3 HP ADGRL3 IGSF3	7.75e-06	169	188	7	849a8f8509c58d65462a09c84d58b6ecdc8934f5
ToppCell	metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac\|metastatic_Lymph_Node / Location, Cell class and cell subclass	NPHS1 PTGS1 FAM151B RND1 LPO ZNF324 ATG9A	8.69e-06	172	188	7	f673a2e697b46e7cfa4186cb3fb2b98e3c83703e
ToppCell	droplet-Kidney-nan-3m-Epithelial-Pecam____kidney_capillary_endothelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NPHS1 CCDC73 PCDH12 EMILIN1 PIEZO2 HECW2 ADGRL3	8.69e-06	172	188	7	073a503dc922e3e3ac3528e249b0f8b74402110b
ToppCell	facs-Marrow-B-cells-24m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 ATP13A5 ADGRV1 CSMD3 FREM1 FAM151A NOS1	9.73e-06	175	188	7	887e75fc90e59a6394d62f3c048a9cfdf6707725
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYNE1 SIRPA ACTN1 LYST FANCA HP FES	1.05e-05	177	188	7	065bebd22031f143e90a407f952b444a3f8818c7
ToppCell	facs-Marrow-Granulocytes-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYNE1 SIRPA ACTN1 LYST FANCA HP FES	1.05e-05	177	188	7	eb304f20aab075bd17aa3aef819386c0e1a235bd
ToppCell	COVID-19-Endothelial_cells-Capillary_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	DLL4 SYNE1 SPTBN1 LAMA5 SHROOM2 HECW2 ADGRL3	1.21e-05	181	188	7	c5f9c92af1384d9089c65afdf41c6feb8345a3ae
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK2 LRRTM3 EMILIN1 FREM1 RND3 PIEZO2 SORCS3	1.60e-05	189	188	7	a153b83314cf52808f685296cff8c95af3f4983d
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CACNA2D1 FRAS1 DYNC2H1 CMYA5 CSMD3 FREM1 PIEZO2	1.60e-05	189	188	7	203c80030df08ae112f9ae4043709f455d87ce89
ToppCell	ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_Lymphatics\|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	EVC2 ANK2 SIRPA CMYA5 OMG PIEZO2 MICAL2	1.66e-05	190	188	7	9ce301841ce9486701fa28eb2a9929e35d476878
ToppCell	Control-Endothelial-VE_Venous\|Endothelial / Disease state, Lineage and Cell class	ACTN1 LYST PTGS1 MET RND1 CSF2RB NOS1	1.66e-05	190	188	7	4e30155203b4a8c5e496fcbe9348b67b98ebc625
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SDK2 ANK2 EMILIN1 FREM1 RND3 PIEZO2 SORCS3	1.71e-05	191	188	7	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VIL1 SDK2 ANK2 EMILIN1 PRSS53 FAM151A GNS	1.71e-05	191	188	7	3387b95a3f2445c672d407922fdce3a91eabaef8
ToppCell	COPD-Endothelial-VE_Arterial\|Endothelial / Disease state, Lineage and Cell class	KIF13B LYST RND3 MET RND1 NOS1 PDZD2	1.71e-05	191	188	7	ef16ad1c1cd2c0c0377957398c98775b62a81754
ToppCell	facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VIL1 CACNA2D1 SDK2 TULP4 PRSS53 FAM151A MUC4	1.77e-05	192	188	7	5b7093d5af5ae7b0e6d3a464cc56272440ecedad
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK2 LRRTM3 EMILIN1 FREM1 RND3 PIEZO2 SORCS3	1.77e-05	192	188	7	dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708
ToppCell	facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l27\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADCY4 DLL4 PTGS1 RSAD2 PIEZO2 RND1 HECW2	1.77e-05	192	188	7	5012cc3ec0766f06af447463413422b484446c43
ToppCell	ILEUM-inflamed-(7)_Endothelial_cell-(7)_Lymphatics\|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	ANK2 CMYA5 EMILIN1 OMG PIEZO2 MICAL2 IGSF3	1.77e-05	192	188	7	d43caf42ec744e895137f31ef65a990e250669d2
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SDK2 ANK2 LRRTM3 EMILIN1 FREM1 PIEZO2 SORCS3	1.77e-05	192	188	7	deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SECISBP2L SYNE1 ADGRV1 FRMD4B PPP4R4 MET MICAL2	1.83e-05	193	188	7	fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	CACNA2D1 FAT4 FRAS1 SDK2 EMILIN1 FREM1 PIEZO2	1.83e-05	193	188	7	acad568621ed677031797b8c2e34dafea798d681
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SECISBP2L SYNE1 ADGRV1 FRMD4B PPP4R4 MET MICAL2	1.83e-05	193	188	7	f3cc7cfdbc164a4ed42f87647111522b7d393bcb
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CACNA2D1 FAT4 SDK2 CSMD3 EMILIN1 FREM1 PIEZO2	1.89e-05	194	188	7	011e14d9ed1393275f892060e7708ffadcd0767f
ToppCell	5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ADCY4 SPTBN1 CNTNAP3 SIRPA ACTN1 PCDH12 PIEZO2	1.89e-05	194	188	7	937ee85ffd50869b60f0f6e91017ab77e8b24c0b
ToppCell	10x5'v1-week_14-16-Endothelial-stroma-proliferating_EC\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	ADCY4 DLL4 PROCR PCDH12 SHROOM2 PIEZO2 HECW2	1.89e-05	194	188	7	8a4be91414a2e69dd410aa75791f16008204c9a1
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SECISBP2L SYNE1 ADGRV1 FRMD4B MET MICAL2 PDZD2	1.89e-05	194	188	7	97534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DLL4 SYNE1 SPTBN1 PCDH12 PIEZO2 SEMA5B HECW2	1.96e-05	195	188	7	23ced69fd904f1d4114b1a7f99f4b5f65ea8824b
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	CACNA2D1 FAT4 SPTBN1 EMILIN1 FRMD4B FREM1 PIEZO2	1.96e-05	195	188	7	1cdf5f296029ae424d9dba42e86a6d111e4896e6
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ADCY4 CPXM2 SPTBN1 ACTN1 LYST PTGS1 NOS1	1.96e-05	195	188	7	81a98ebb0d43f416f9a8bba580531dc0cfea8f74
ToppCell	facs-Lung-nan-3m-Endothelial\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 DLL4 SPTBN1 LRRC58 PIEZO2 MICAL2 HECW2	1.96e-05	195	188	7	7f9b7f15006610ad591063d90e90367bd6083c7f
ToppCell	367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	FRAS1 SDK2 SPTBN1 EMILIN1 OMG FRMD4B PIEZO2	2.02e-05	196	188	7	6730743cf088c419ccc2d28765769fc09d3ba6a7
ToppCell	367C-Fibroblasts-Fibroblast-C_(Myofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	FRAS1 SDK2 SPTBN1 EMILIN1 OMG FRMD4B PIEZO2	2.02e-05	196	188	7	21dab89f3699037138a9c7a0e4dc98739a9fad9c
ToppCell	COVID-19-lung-Capillary_Aerocytes\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SYNE1 SPTBN1 LAMA5 PCDH12 SHROOM2 STARD9 HECW2	2.02e-05	196	188	7	49cc0a2b9739abad61dff7292ea0b14d28ff35c4
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LRRTM3 CMYA5 CSMD3 SORCS3 NOS1 ADGRL3 PDZD2	2.02e-05	196	188	7	f374cb3ec31c6eef2cef9e07547bfd1e380553af
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LRRTM3 CMYA5 CSMD3 SORCS3 NOS1 ADGRL3 PDZD2	2.02e-05	196	188	7	671c380b58d7f634b4fbec38c357d357ea4f3535
ToppCell	356C-Endothelial_cells-Endothelial-F_(Lymphatics)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	ADCY4 SYNE1 EMILIN1 OMG PIEZO2 MICAL2 IGSF3	2.02e-05	196	188	7	b04ca69b0ed44e09c989b575f747e1e819cd8008
ToppCell	356C-Endothelial_cells-Endothelial-F_(Lymphatics)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	ADCY4 SYNE1 EMILIN1 OMG PIEZO2 MICAL2 IGSF3	2.02e-05	196	188	7	a31e227de2dc077b81881295b012d22fedbd65ed
ToppCell	COVID-19-lung-Capillary_Aerocytes\|lung / Disease (COVID-19 only), tissue and cell type	SYNE1 SPTBN1 LAMA5 PCDH12 SHROOM2 STARD9 HECW2	2.02e-05	196	188	7	4ac4073380d939a73cec7413e9f3f5ef616d2924
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SDK2 ANK2 DYNC2H1 SYNE1 FREM1 RND3 SORCS3	2.09e-05	197	188	7	fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell	343B-Endothelial_cells-Endothelial-A_(Artery)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	CPXM2 ACTN1 LYST PTGS1 RND3 MET MRPL40	2.09e-05	197	188	7	ec92d60f802c9d4bdf9877bed5c0a91a5a5ed5d0
ToppCell	343B-Endothelial_cells-Endothelial-A_(Artery)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	CPXM2 ACTN1 LYST PTGS1 RND3 MET MRPL40	2.09e-05	197	188	7	7bec9c1bc8851064eb229324493b47a31201c83c
ToppCell	IPF-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	KIF13B FAT4 SDK2 EMILIN1 FRMD4B PIEZO2 VPS13B	2.09e-05	197	188	7	f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCell	10x5'v1-week_12-13-Endothelial-stroma\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	CACNA2D1 ADCY4 PROCR CNTNAP3 LAMA5 PCDH12 PIEZO2	2.16e-05	198	188	7	122215d9288533ad03562cf777e846504863df9a
ToppCell	10x5'v1-week_12-13-Endothelial\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	CACNA2D1 ADCY4 PROCR CNTNAP3 LAMA5 PCDH12 PIEZO2	2.16e-05	198	188	7	307dd09e6bc820a148f3000f18dae7aedba4be0b
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	CACNA2D1 FRAS1 ANK2 EMILIN1 RND3 PIEZO2 KIRREL1	2.16e-05	198	188	7	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_ALM_Slco2a1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	FRAS1 SDK2 ADAM18 PTGS1 LRRC9 MET	2.17e-05	133	188	6	9d7a08170d38ae9b2ff10a0fa505aeb3aae2824d
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ADCY4 DLL4 PROCR CNTNAP3 SPTBN5 HECW2 CRAMP1	2.23e-05	199	188	7	d95d78b2ebc9a20532466e4d4be579b4faf6776f
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ADCY4 DLL4 PROCR CNTNAP3 SPTBN5 HECW2 CRAMP1	2.23e-05	199	188	7	cdcfca94baba66e213cc3ffb0cfb4c75d6ab44ec
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SDK2 ANK2 DYNC2H1 SYNE1 FREM1 RND3 SORCS3	2.23e-05	199	188	7	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SDK2 ANK2 SYNE1 EMILIN1 FREM1 RND3 SORCS3	2.23e-05	199	188	7	e1849505b92820a219c5a2c35492bdd55579fb48
ToppCell	Hematolymphoid-Endothelial-NOSTRIN\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	SYNE1 SPTBN1 ACTN1 RND3 CEP112 YWHAQ PDZD2	2.30e-05	200	188	7	032df80aa5c40991e1c1e80f9d8da106e6aeaee2
ToppCell	Hematolymphoid-Endothelial-NOSTRIN---\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	SYNE1 SPTBN1 ACTN1 RND3 CEP112 YWHAQ PDZD2	2.30e-05	200	188	7	68fce28690246895fd33354b30960ebcc31aa4cc
ToppCell	Hematolymphoid-Endothelial-NOSTRIN-\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	SYNE1 SPTBN1 ACTN1 RND3 CEP112 YWHAQ PDZD2	2.30e-05	200	188	7	376b19ab5a7cd2c85f726d8ba41337d4525863e5
ToppCell	Hematolymphoid-Endothelial-NOSTRIN--\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	SYNE1 SPTBN1 ACTN1 RND3 CEP112 YWHAQ PDZD2	2.30e-05	200	188	7	7fa54370221ed61bac0e09e6bcf1f3dff202a846
ToppCell	Hematolymphoid-Endothelial-NOSTRIN----L2-6\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	SYNE1 SPTBN1 ACTN1 RND3 CEP112 YWHAQ PDZD2	2.30e-05	200	188	7	878bbbe32e3602723aa14ef32877ab2453b8c6e5
ToppCell	control-HLA-DR-_S100A+_Monocyte\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	IRF5 SIRPB1 SIRPA LYST HP FES GNS	2.30e-05	200	188	7	9e3e13a68bc1110fa000ec2d80f4c654ddbce17e
ToppCell	Hematolymphoid-Endothelial\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	SYNE1 SPTBN1 ACTN1 RND3 CEP112 YWHAQ PDZD2	2.30e-05	200	188	7	7136936d05ab344a560cf159684c881063b5430d
ToppCell	PBMC-Mild-cDC_2\|Mild / Compartment, Disease Groups and Clusters	EVC2 AARD ZNF285 PPP4R4 TRPV3 PDZD2	2.36e-05	135	188	6	cb9d834f8301cf53f20e09c3f4cb6a148690196a
ToppCell	PBMC-Severe-Myeloid-Neutrophil-Neutrophil-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	DLL4 RSAD2 CSF2RB OR12D2 FAM151A ADGRE3	2.78e-05	139	188	6	fa0eedebf53317928022c3bed391ce99a2114f98
ToppCell	facs-Trachea-18m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_trachea\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	LCN8 SIRPA CSF2RB SORCS3 NOS1 CNTN2	2.78e-05	139	188	6	96e6fed23e7a69f678f85e8e2fe77a7491586b4b
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo1_Itga4\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	FAT4 CSMD3 SEMA5B SORCS3 SLC2A13 IGSF3	3.40e-05	144	188	6	7de962346ba9653d90dd13bb7d977fe44d200bba
ToppCell	facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 PKD2L1 ATP13A5 ADGRV1 CSMD3 NWD2	3.53e-05	145	188	6	96712c68ab759d7ade0d912581a1a7c25dc6def8
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	KIF13B CPXM2 CSMD3 FREM1 LRRC9 TBL1X	4.60e-05	152	188	6	655d47efe0608d729801f1f01668e84c1bc0675f
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo4_Rxfp1_Chat\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	FAT4 CSMD3 SEMA5B SORCS3 SLC2A13 IGSF3	5.12e-05	155	188	6	3b8def9e8f66511736ea37f259511f7c8b7743af
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LRRTM3 CMYA5 SPTBN5 SEMA5B SORCS3 ADGRL3	5.12e-05	155	188	6	77fdae85d36efb776db977eb424b32487ef222e4
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ADCY4 CNTNAP3 SHROOM2 PTGS1 CSF2RB TDRD6	6.11e-05	160	188	6	33050dc646762dc7e9dcc4a12c618e1ba1ce5a4d
ToppCell	PND01-03-samps\|World / Age Group, Lineage, Cell class and subclass	ADCY4 SPTBN1 LGALS4 RSAD2 HP HECW2	6.33e-05	161	188	6	1973b112d8d67aacc02751797d0148e7b53bfa66
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FRAS1 PKD2L1 ATP13A5 ADGRV1 CSMD3 NWD2	6.55e-05	162	188	6	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	IRF5 SIRPA TICAM2 NWD2 CSF2RB HP	6.55e-05	162	188	6	9d6931619f5eb847c79d00ff5ae031fef30fd55c
ToppCell	facs-Liver-Liver_non-hepato/SCs-18m-Myeloid-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IRF5 SIRPA TICAM2 FANCA CSF2RB FES	7.01e-05	164	188	6	45a6d809d92fd4eee906da3c812282bacffc9f2f
ToppCell	facs-Liver-Liver_non-hepato/SCs-18m-Myeloid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IRF5 SIRPA TICAM2 FANCA CSF2RB FES	7.01e-05	164	188	6	aa4358311fc767c292897e3328309d1bcda392d4
ToppCell	facs-Lung-ENDOMUCIN-18m-Myeloid-Classical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IRF5 SIRPA TICAM2 CSF2RB HP FES	7.49e-05	166	188	6	82fa07632f7e586698fbf37381715b40f9f6ae3a
ToppCell	facs-Lung-ENDOMUCIN-18m-Myeloid-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IRF5 SIRPA TICAM2 CSF2RB HP FES	7.49e-05	166	188	6	0d03926452414f232c77fd15d5f48d148f9fca3b
ToppCell	PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CCDC73 PEX7 SNX33 ABCC6 THADA NOC4L	8.00e-05	168	188	6	08f6e171a1ea5cf65149744296d0fcd6c7b9684e
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DLL4 SYNE1 SPTBN1 PIEZO2 SEMA5B HECW2	8.27e-05	169	188	6	987ff79ad563825dd9877ea8ccb536758f8c6700
ToppCell	droplet-Spleen-SPLEEN-30m-Myeloid-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYNE1 SIRPA ACTN1 PTGS1 HP FES	8.27e-05	169	188	6	1000eaf5158596b4898bedcc802b31db76b05a48
ToppCell	droplet-Spleen-SPLEEN-30m-Myeloid\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYNE1 SIRPA ACTN1 PTGS1 HP FES	8.27e-05	169	188	6	83b854fa8fd9017df8f9207d9ced260eee98e8c1
ToppCell	P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ASPG LRRTM3 ADGRV1 THADA FAM151A KIRREL1	8.54e-05	170	188	6	ba4ba66b624089ed50a9083176386c7941b4c7a3
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Penk_Col27a1\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	NPHS1 SDK2 ASPG SPTBN5 SEMA5B SORCS3	8.82e-05	171	188	6	d07e2c5f7d7f12c68860d4161d76372de174f1d8
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ASPG SYNE1 RND3 PIEZO2 SEMA5B HECW2	1.00e-04	175	188	6	12f5fd83c7710fc0c77406f765d9cbd133433b8b
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium_(RGS5+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NPHS1 FRAS1 SPATA31E1 PROCR LAMA5 FRMD4B	1.00e-04	175	188	6	f5451c29c487b998778e50349b3d774d5e20fd28
Disease	Ciliopathies	EVC2 DYNC2H1 ADGRV1 CEP164 WDR19 GUCY2D CPLANE1 NODAL	4.13e-07	110	181	8	C4277690
Disease	Jeune thoracic dystrophy	DYNC2H1 IFT172 WDR19	3.61e-05	11	181	3	C0265275
Disease	Malignant neoplasm of breast	ANK2 DLL4 DYNC2H1 SYNE1 APC2 FAM131A SHROOM2 MAMDC4 PTGS1 IFNB1 SEMA5B SBNO1 HP TRAPPC12 PLD2 VPS13B PLXNB1 DOP1A DNMT1	3.64e-05	1074	181	19	C0006142
Disease	level of tyrosine-protein phosphatase non-receptor type substrate 1 in blood serum	SIRPB1 SIRPA	3.74e-05	2	181	2	OBA_2040362
Disease	autosomal recessive nonsyndromic deafness 16 (implicated_via_orthology)	STRC STRCP1	3.74e-05	2	181	2	DOID:0110471 (implicated_via_orthology)
Disease	Polydactyly	FRAS1 EVC2 DYNC2H1 IFT172 CEP164 CPLANE1	8.73e-05	117	181	6	C0152427
Disease	Fraser syndrome (implicated_via_orthology)	FRAS1 FREM1	2.23e-04	4	181	2	DOID:0090001 (implicated_via_orthology)
Disease	Jeune thoracic dystrophy	DYNC2H1 WDR19	2.23e-04	4	181	2	cv:C0265275
Disease	congenital stationary night blindness (is_implicated_in)	GUCY2D TRPV3	2.23e-04	4	181	2	DOID:0050534 (is_implicated_in)
Disease	Disorder of eye	FRAS1 PEX7 ADGRV1 LRIT3 FREM1 GUCY2D CPLANE1	3.50e-04	212	181	7	C0015397
Disease	Brugada Syndrome (disorder)	CACNA2D1 ANK2 SLMAP	4.18e-04	24	181	3	C1142166
Disease	acute kidney failure (biomarker_via_orthology)	PROCR MET HP NOS1	5.44e-04	61	181	4	DOID:3021 (biomarker_via_orthology)
Disease	VACTERL association (implicated_via_orthology)	DYNC2H1 IFT172	5.52e-04	6	181	2	DOID:14679 (implicated_via_orthology)
Disease	response to surgery, post-operative sign or symptom	KIF13B SIRPA	5.52e-04	6	181	2	EFO_0005323, EFO_0009951
Disease	Abnormality of the eye	APC2 FBXW11	7.70e-04	7	181	2	C4316870
Disease	schizophrenia (implicated_via_orthology)	CSMD3 YWHAZ SBNO1 NOS1	8.21e-04	68	181	4	DOID:5419 (implicated_via_orthology)
Disease	Unilateral agenesis of kidney	FRAS1 FREM1	1.02e-03	8	181	2	C0266294
Disease	ulcerative colitis	CACNA2D1 CPXM2 PROCR IRF5 LRRTM3 KPNA7 SLC2A13 TAP2	1.14e-03	335	181	8	EFO_0000729
Disease	margarate 17:0 measurement	PKD2L1 FREM1	1.31e-03	9	181	2	EFO_0021066
Disease	Coronavirus infectious disease (implicated_via_orthology)	TICAM2 MUC4	1.31e-03	9	181	2	DOID:0080599 (implicated_via_orthology)
Disease	signal-regulatory protein beta-1 measurement	SIRPB1 SIRPA	1.31e-03	9	181	2	EFO_0802069
Disease	cystic kidney disease (implicated_via_orthology)	IFT172 LAMA5	1.63e-03	10	181	2	DOID:2975 (implicated_via_orthology)
Disease	myositis	SDK2 MICB CCDC116	1.76e-03	39	181	3	EFO_0000783
Disease	Stevens-Johnson syndrome, toxic epidermal necrolysis, response to methazolamide	MICB TAP2	1.98e-03	11	181	2	EFO_0004276, EFO_0004775, EFO_0020996
Disease	cardiovascular disease	USP36 CYP27B1 PKD2L1 FREM1 SPTBN5 THADA FES SORCS3 DNMT1	2.14e-03	457	181	9	EFO_0000319
Disease	aseptic loosening, revision of total knee arthroplasty	CPXM2 IFNAR1 ADGRL3	2.19e-03	42	181	3	EFO_0010725, EFO_0020972
Disease	Renal dysplasia and retinal aplasia (disorder)	CEP164 WDR19	2.37e-03	12	181	2	C0403553
Disease	retinopathy of prematurity (biomarker_via_orthology)	DLL4 NOS1	2.37e-03	12	181	2	DOID:13025 (biomarker_via_orthology)
Disease	cholangiocarcinoma (biomarker_via_orthology)	MET MUC4	2.79e-03	13	181	2	DOID:4947 (biomarker_via_orthology)
Disease	Short Rib-Polydactyly Syndrome	DYNC2H1 IFT172	2.79e-03	13	181	2	C0036996
Disease	unipolar depression, bipolar disorder	FAT4 CCDC73 SYNE1 STARD9 SORCS3	2.81e-03	156	181	5	EFO_0003761, MONDO_0004985
Disease	response to hydrochlorothiazide, triglyceride measurement	SEC31B PIEZO2 DNMT1	3.02e-03	47	181	3	EFO_0004530, EFO_0005202
Disease	hearing impairment	ADGRV1 FANCA PNPT1 DNMT1	3.16e-03	98	181	4	C1384666
Disease	Saldino-Noonan Syndrome	DYNC2H1 IFT172	3.24e-03	14	181	2	C0036069
Disease	Majewski Syndrome	DYNC2H1 IFT172	3.24e-03	14	181	2	C0024507
Disease	renal cell carcinoma (biomarker_via_orthology)	OGG1 PTGS1	3.24e-03	14	181	2	DOID:4450 (biomarker_via_orthology)
Disease	opioid dependence	FAT4 ADGRV1 CSMD3 OGG1 PTGS1 NWD2	3.53e-03	237	181	6	EFO_0005611
Disease	Down syndrome (implicated_via_orthology)	DOP1A DOP1B	3.73e-03	15	181	2	DOID:14250 (implicated_via_orthology)
Disease	Inherited oocyte maturation defect	ASTL KPNA7	4.24e-03	16	181	2	cv:CN238505
Disease	congestive heart failure (biomarker_via_orthology)	HP PLD2 NOS1 DNMT1	4.33e-03	107	181	4	DOID:6000 (biomarker_via_orthology)
Disease	hair colour measurement	FRAS1 ASPG PROCR ADGRV1 LYST NDUFS4 FANCA THADA FES FOLH1B	4.86e-03	615	181	10	EFO_0007822
Disease	vascular endothelial growth factor measurement	EVC2 ATP13A5 SEMA5B	4.96e-03	56	181	3	EFO_0004762
Disease	urate measurement, bone density	FRAS1 SYNE1 PARG LAMA5 FREM1 FANCA RND3 CSF2RB ADGRE3 PDZD2	5.08e-03	619	181	10	EFO_0003923, EFO_0004531
Disease	systemic lupus erythematosus, COVID-19	IRF5 MICB TAP2	5.47e-03	58	181	3	MONDO_0007915, MONDO_0100096
Disease	Drug habituation	SYNE1 EIPR1 CSMD3 SLC2A13	5.58e-03	115	181	4	C0013170
Disease	Drug abuse	SYNE1 EIPR1 CSMD3 SLC2A13	5.58e-03	115	181	4	C0013146
Disease	Prescription Drug Abuse	SYNE1 EIPR1 CSMD3 SLC2A13	5.58e-03	115	181	4	C4316881
Disease	Substance-Related Disorders	SYNE1 EIPR1 CSMD3 SLC2A13	5.58e-03	115	181	4	C0236969
Disease	Drug Use Disorders	SYNE1 EIPR1 CSMD3 SLC2A13	5.58e-03	115	181	4	C0013222
Disease	Drug Dependence	SYNE1 EIPR1 CSMD3 SLC2A13	5.58e-03	115	181	4	C1510472
Disease	Substance Dependence	SYNE1 EIPR1 CSMD3 SLC2A13	5.58e-03	115	181	4	C0038580
Disease	Substance Use Disorders	SYNE1 EIPR1 CSMD3 SLC2A13	5.58e-03	115	181	4	C0038586
Disease	Organic Mental Disorders, Substance-Induced	SYNE1 EIPR1 CSMD3 SLC2A13	5.58e-03	115	181	4	C0029231
Disease	Carcinoma, Granular Cell	FAT4 OGG1 MET DNMT1	5.75e-03	116	181	4	C0205644
Disease	Adenocarcinoma, Tubular	FAT4 OGG1 MET DNMT1	5.75e-03	116	181	4	C0205645
Disease	Adenocarcinoma, Oxyphilic	FAT4 OGG1 MET DNMT1	5.75e-03	116	181	4	C0205642
Disease	Carcinoma, Cribriform	FAT4 OGG1 MET DNMT1	5.75e-03	116	181	4	C0205643
Disease	Adenocarcinoma, Basal Cell	FAT4 OGG1 MET DNMT1	5.75e-03	116	181	4	C0205641
Disease	Adenocarcinoma	FAT4 OGG1 MET DNMT1	5.75e-03	116	181	4	C0001418
Disease	Substance abuse problem	SYNE1 EIPR1 CSMD3 SLC2A13	5.75e-03	116	181	4	C0740858
Disease	polycystic kidney disease (biomarker_via_orthology)	DLL4 PTGS1	5.97e-03	19	181	2	DOID:0080322 (biomarker_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
TQWRLVSDEAVTNGL	VANGL1	461	Q8TAA9
VDNGSRELAWQALSS	MAMDC4	581	Q6UXC1
AQQLSSLEGWTGQDR	LINC00479	21	Q96M42
DTRDLWTTTTLSQAQ	CATSPERZ	26	Q9NTU4
WLIRSGSSQNESQED	nan	81	P0DMU3
ERALWQADTQVTSGV	PROCR	146	Q9UNN8
LRDNLTLWTSDSAGE	YWHAQ	221	P27348
EQSWTGVEATLARLR	AARD	91	Q4LEZ3
NVSLERNWTGNATLI	ATP13A5	1021	Q4VNC0
AGRNEWTSDTIVLSQ	CNTNAP3	741	Q9BZ76
GWEQLLTTIARTINE	ACTN1	716	P12814
QRDSLLWDSLGSQTS	CCDC116	216	Q8IYX3
RGLTLSSTSNQLWLE	CSMD3	1316	Q7Z407
LARVTALWEDSSNGQ	DNMT1	776	P26358
LSSLELWSNENQIST	ADAM18	231	Q9Y3Q7
NDTGWISVASSLISD	FAT4	3036	Q6V0I7
QALNAWRDLTTSDQL	ADGRL3	636	Q9HAR2
SRTNGIDLAVSVQWE	ADGRV1	3226	Q8WXG9
DSDIEARLNSWNLGI	CEP112	201	Q8N8E3
LIETLSQWRSVETGS	CAMTA2	726	O94983
SQWRSVETGSLDLEQ	CAMTA2	731	O94983
VGQNWLLDEQTSTLT	DLL4	151	Q9NR61
IQVTEETAWALQSLG	ADCY4	1026	Q8NFM4
GLLQSRELGNSWTVT	LINC02910	76	Q8N268
IAGSSLEQTTWLRRN	DOP1A	1981	Q5JWR5
IGQRWNLSASDITRV	ASTL	261	Q6HA08
QALISRLQWDGSSDL	ATXN7L3	266	Q14CW9
SALANLTWQSRTQDE	ASH2L	171	Q9UBL3
TGVITQGRNSLWLSD	CPXM2	206	Q8N436
TVLTALENGSISTWD	NWD2	981	Q9ULI1
LENGSISTWDVETRQ	NWD2	986	Q9ULI1
TNASSLIGSEWELEI	PCDH12	661	Q9NPG4
VVRNSLLNGSWGSEE	LGALS4	246	P56470
TRLSINNNLLTGWEE	LRRC9	956	Q6ZRR7
RLSWGTENLDNVALS	ANK2	946	Q01484
RENRSGWTVLQEAVS	ANKRD13B	76	Q86YJ7
LAGVDTVSNTLSWAL	CYP27B1	316	O15528
AGTAEIDLSDWRNNT	HECW2	1451	Q9P2P5
QLVRANTNSLEVSWG	HCFC1	371	P51610
QWTQETGTTGEALLS	MUC4	566	Q99102
ESQWTGERDTQSSTV	NPHS1	1116	O60500
WALTNIASGTSEQTR	KPNA7	136	A9QM74
RIWLDNLSCSGTEQS	LOXL3	106	P58215
LWRTGIQTDSVLSAR	FRAS1	3506	Q86XX4
TTGATLINEQWLLTT	HP	186	P00738
QDLWVEAGRSLSTAL	GUCY2D	191	Q02846
VWRDVSLDSVLVNNG	LGALS16	126	A8MUM7
VSWLLSLSGSQEADA	ASPG	381	Q86U10
GIQWVTETALVNSSR	MMS22L	76	Q6ZRQ5
QREEWNLSTGQARLT	ATAD2B	111	Q9ULI0
QWTESVGLTLVSRDL	ATP9B	596	O43861
NIAGSSLEQTSWLSR	DOP1B	1841	Q9Y3R5
DQSRESNIWSLGVTL	LMTK3	326	Q96Q04
ILRWNRSDESVGNVT	IFNAR1	46	P17181
DVTSEVQGLWRRLNT	PLXNB1	1821	O43157
WREVGVASDQSLVLT	LCN8	36	Q6JVE9
TAGSRWELIQTALLN	PARG	531	Q86W56
RSWSVNLDQLLVSAG	PDZD2	2571	O15018
TRTAIRNGQVWEESL	LPO	81	P22079
SVDWSQTRGEQLVVS	PEX7	116	O00628
VVSGSSDNTIRLWDI	FBXW11	416	Q9UKB1
RNSQITAEDGAEITW	FAM151B	21	Q6UXP7
VSWNTGLSLLEGQSR	FREM1	416	Q5H8C1
LGSTEWAEDNSRLLQ	FOLH1B	121	Q9HBA9
GSSEAQTARIWLLVN	EVC2	176	Q86UK5
ERNSSSIWSLELSGN	LRRC74A	186	Q0VAA2
SQLTAALTSWAQRRG	LMLN2	216	A0A1B0GTW7
GDDSQWSLLLVVTST	LRIT3	576	Q3SXY7
TLTWRQDGVSLSHNT	MICB	236	Q29980
SSAELQQQWLETLST	FGD3	686	Q5JSP0
SGELSWSADSIRLQI	IRF5	431	Q13568
LSSLWEENQALATQT	LAMA5	2356	O15230
SGVLADQVWTLTQTE	OGG1	56	O15527
ELNQWLLSTVTGTIA	OR12D2	191	P58182
TWGDEQLFQTTRLIL	PTGS1	321	P23219
LWDLQESSSQAVLAS	EIPR1	161	Q53HC9
AGEAELNWSRLSVST	LRRC58	11	Q96CX6
TILASSGTDRRLNVW	RBBP4	331	Q09028
LVELLSGLQASWASD	PKD1L2	446	Q7Z442
DLNTNRLSEIAWQGS	IFT172	381	Q9UG01
LEERNTALGVISNWT	NOS1	1071	P29475
QISQSWDESLSLSDS	PABIR2	81	Q7Z309
NETGLTDLTLETVWN	ACP2	191	P11117
ASGNWRTQLTIGLSD	FRMD4B	956	Q9Y2L6
TREWSDGVLTNSARQ	DYNC2H1	2026	Q8NCM8
LDSVEWRAIQEGANS	APC2	1681	O95996
SWEDAAILLSNTSQA	CSF2RB	181	P32927
NTWTRLAERTSNLLE	IGSF3	656	O75054
VLTTSSNDAWLAGVL	CPLANE1	66	Q9H799
ITEWSLQSLGEELSS	CCDC18	31	Q5T9S5
STIVLNELNWTSALD	CACNA2D1	176	P54289
LGLNTSWERVSTEVR	DCST1	346	Q5T197
SDNTLEQWLDAVLGS	FAM151A	121	Q8WW52
SGWSVAASLQRQREL	FANCA	1061	O15360
SSVWEGQLQSLVLSE	ATG9A	686	Q7Z3C6
VQREDSGITWETNSS	CMYA5	76	Q8N3K9
DTTSINRVADTLNNW	CCDC73	966	Q6ZRK6
EGWNLQTSESLTLAE	CRAMP1	676	Q96RY5
SSTGWNETIVENLLA	IFNB1	96	P01574
TGSWERQRQASDLAS	FAM131A	336	Q6UXB0
DWQGTSIDRNILDAL	ADA2	361	Q9NZK5
QTRSDLLLSGRDWNT	PRMT5	66	O14744
VRDIGDTTIQLSWSR	CNTN2	616	Q02246
NIDRELGSANVISWN	DNAJC13	796	O75165
SLSDNLESRVVSAGW	LYST	301	Q99698
RGASNLTWRSDVLVE	GNS	401	P15586
TLIQLESWFTATGQT	KHDC1	126	Q4VXA5
VWILTLSDTFSQGTQ	KIRREL1	6	Q96J84
GVEVLSTSWEEQRAS	CENPO	256	Q9BU64
AGLWAGLRETNTTSQ	EMILIN1	756	Q9Y6C2
WTQGNRLSTVTLATV	ERVFC1	41	P60507
WLVEGNSSRSAQLTG	SDK2	1251	Q58EX2
SEETIDNGWLSALQL	SBNO1	281	A3KN83
RTSTWRLAQDQTQDT	NDUFS4	36	O43181
AQSRALESSLWELQA	NOC4L	426	Q9BVI4
VSNVAGNDSLRTWLE	LINGO4	486	Q6UY18
VNVTDLTTSWRSGLA	MICAL2	536	O94851
IDTQRIELSLWDTSG	RND3	66	P61587
TNTSDLGQRIWDVAD	P2RX5	76	Q93086
QSWAEITSQTEGLSR	FES	71	P07332
DALWQELLVSSTVGA	SLC2A13	116	Q96QE2
GRWESQQDVSQTTVS	KIF13B	1406	Q9NQT8
VRSEECLSGTWTQQI	MET	546	P08581
TSGLLGTWQTQLRET	MRPL40	16	Q9NQ50
LSRILASWTNSAIQV	THADA	356	Q6YHU6
LSREIQEAAATRGQW	TDRD6	46	O60522
RQWSRALISGIQSVE	TDRD6	831	O60522
DTGVSNAWLETLLSV	PPP4R4	146	Q6NUP7
RSGLSEVVEASSLSW	SFT2D2	16	O95562
SVSIVSNGSLIRERW	RSAD2	151	Q8WXG1
DVLSTRDEIEGWSNN	SYNE1	2201	Q8NF91
LSRIDSQWTDLLTNI	SYNE1	6881	Q8NF91
TWSSLQRLDLSGNEI	LRRTM3	251	Q86VH5
SQEQRQLGGSTLLWE	NODAL	201	Q96S42
LWSLGRENSSEELVS	ABCC6	236	O95255
NLGSVTESSLWRSTD	SORCS3	221	Q9UPU3
TEEQRVELSLWDTSG	RND1	56	Q92730
ESAWVLTNIASGNSL	KPNA1	146	P52294
WVSTDLSQTELRDGQ	SOCS4	161	Q8WXH5
SETSLDGWLQGQNSR	SNX33	31	Q8WV41
TWLENGNVSRTETAS	SIRPA	286	P78324
LSSSWEQTNLQRTLD	SHROOM2	156	Q13796
QDWNSRGDRTVLVIA	TAP2	646	Q03519
LEWASQQSTETGSLD	SECISBP2L	951	Q93073
LNSESLATTVWVSRN	SPATA31E1	446	Q6ZUB1
TSSENWIRNATVNIL	NLRP7	61	Q8WX94
DDAVNGSAWTILLLT	TICAM2	126	Q86XR7
SWTDDGQLLALSTQR	WDR19	326	Q8NEZ3
RGILSVSWSQADAEL	SEC31B	261	Q9NQW1
SAADTSRLSLWGIQR	STARD9	1416	Q9P2P6
TSDNELEGWLVTRFT	PRAMEF2	246	O60811
TQLQVRALWSSAGSR	PNPT1	31	Q8TCS8
QSTTLNLWREETTTN	OMG	396	P23515
TLGQIDGWSTTQLRI	STRC	1556	Q7RTU9
SWTDSISLARSTGQQ	SPTBN5	2521	Q9NRC6
WLENGNVSRTETAST	SIRPB1	286	Q5TFQ8
LDDFQSWLSRTQTAI	SPTBN1	1071	Q01082
LRDNLTLWTSDTQGD	YWHAZ	221	P63104
QTLWRTEGRQEISST	ADGRE3	146	Q9BY15
LQQWREEGLSQVLST	ANGEL1	61	Q9UNK9
SGREIAQLAVSWQAT	ATAD3B	526	Q5T9A4
ESQRLSWLRAQVQSS	CEP164	666	Q9UPV0
GLQLTWLENGNVSRT	SIRPB1	281	O00241
WLENGNVSRTETAST	SIRPB1	286	O00241
VTSLDWNTNGTLLAT	TBL1X	291	O60907
ELNSWSVVLGSLQRE	PRSS53	86	Q2L4Q9
SSEINLESQITCGIW	TULP4	161	Q9NRJ4
ELGNSRDWSQITAEV	VIL1	731	P09327
WSSTLTVHQRIQTGE	ZNF876P	186	Q49A33
INILLEGNSDTTSWE	UBAP2	86	Q5T6F2
SQEEWGLLDTAQRAL	ZNF324	11	O75467
LSSTAEWVLLDQTRN	ERVFRD-1	221	P60508
LNQASSLRERATQGW	ERVFRD-1	456	P60508
SSVTQEGRQASIRLW	TRAPPC12	526	Q8WVT3
TLVLSASQDGTLRTW	WDR97	346	A6NE52
ASQDGTLRTWDLQAA	WDR97	351	A6NE52
TLRTWDLQAAAQVGE	WDR97	356	A6NE52
RLLAITQEASDTSWQ	SLMAP	191	Q14BN4
DSIIDWLNSVRQTGN	RLIM	96	Q9NVW2
WTDQLGLRNLEVSSC	TNKS1BP1	1161	Q9C0C2
WFGDSLTSLSQRLQI	TMEM214	586	Q6NUQ4
VAELEGNSNSLWTIS	PIEZO2	2496	Q9H5I5
EDLDTSVNLAWTSGT	VDAC2	211	P45880
LANVSLLQATEWASS	SEMA5B	151	Q9P283
WGTTLTENTAENREL	PKD2L1	81	Q9P0L9
VLGSATRDQDQLQAW	UAP1	76	Q16222
TSIWATDLGNEILIA	WDR93	146	Q6P2C0
VSSDLWRIVLNSSQN	VPS13B	2421	Q7Z7G8
LRSGNWELETTRNND	TRPV3	326	Q8NET8
QIDGWSSTQLRIVVS	STRCP1	1556	A6NGW2
QEESLGRGTSLWTEL	TARBP1	561	Q13395
RDNTLLLWDVVTGQS	WDR31	166	Q8NA23
LLWDVVTGQSVERAS	WDR31	171	Q8NA23
NLVWRDVSLGQTSRT	SMIM45	46	A0A590UK83
ARWETQSSISLILEG	PVRIG	106	Q6DKI7
VLRSVDRWSAGTLEN	PLD2	606	O14939
DRWSAGTLENSILNA	PLD2	611	O14939
SLSEEWAGISLQISE	ZNF285	106	Q96NJ3
SVVADQISLLSREWG	ULK1	881	O75385
SQRQGSWDSRDVVLS	USP36	566	Q9P275
SQEEWGLLDTAQRAL	ZNF324B	11	Q6AW86
TASGSEAWAEVQRQL	NAALADL1	706	Q9UQQ1